Back to Search
MOULALI SHAIK, M.D
M.D
Internal Medicine Physician
NPI: 1821261058IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
37608(IA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1995
Research & Publications (20)
Music for medical indications in the neonatal period: a systematic review of randomised controlled trials.
PMID 19477913·Arch Dis Child Fetal Neonatal Ed·2009
1-meta
More late perforations with the Riata defibrillator lead from a high-volume center: an update on the numbers.
PMID 18507558·Pacing Clin Electrophysiol·2008
8-other
Seroprevalence of Toxoplasma gondii antibodies in pigs, goats, cattle, dogs and cats in peninsular Malaysia.
PMID 19287367·Trop Biomed·2008
7-preclinical
Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
PMID 17227616·J Pharm Pharmacol·2007
8-other
Calculation of the relative acidities and oxidation potentials of para-substituted phenols. A model for alpha-tocopherol in solution.
PMID 17520142·Org Biomol Chem·2007
8-other
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
PMID 17159504·Anticancer Drugs·2007
7-preclinical
Paediatric trauma epidemiology in an urban scenario in India.
PMID 17429116·J Orthop Surg (Hong Kong)·2007
8-other
Transferability of quantum topological atoms in terms of electrostatic interaction energy.
PMID 17165885·J Phys Chem A·2006
8-other
Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
PMID 16902813·Pharm Res·2006
7-preclinical
Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.
PMID 16536899·J Pharm Pharmacol·2006
8-other
Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
PMID 16052515·Int J Cancer·2006
7-preclinical
Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer.
PMID 15835749·Pharm Res·2005
4-observational
Perforated colonic diverticulum presenting as necrotizing fasciitis of the thigh.
PMID 16193368·J Orthop Sci·2005
5-case
Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
PMID 15233869·J Pharm Pharmacol·2004
8-other
Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.
PMID 15176062·J Pharm Sci·2004
8-other
Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.
PMID 14977856·Clin Cancer Res·2004
7-preclinical
Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers.
PMID 14705192·J Pharm Sci·2004
4-observational
Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line.
PMID 14567645·Pharm Res·2003
4-observational
Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin.
PMID 12841943·J Pharm Pharmacol·2003
7-preclinical
Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug.
PMID 12396414·J Aerosol Med·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 120 E HARRIS AVE
SAN ANGELO, TX 76903 - Phone
- (325) 658-1511
Quick Facts
- NPI
- 1821261058
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile